Probing the open state of cytochrome P450cam with ruthenium-linker substrates

Proceedings of the National Academy of Sciences of the United States of America
A R DunnB R Crane

Abstract

Cytochromes P450 play key roles in drug metabolism and disease by oxidizing a wide variety of natural and xenobiotic compounds. High-resolution crystal structures of P450cam bound to ruthenium sensitizer-linked substrates reveal an open conformation of the enzyme that allows substrates to access the active center via a 22-A deep channel. Interactions of alkyl and fluorinated biphenyl linkers with the channel demonstrate the importance of exploiting protein dynamics for specific inhibitor design. Large changes in peripheral enzyme structure (F and G helices) couple to conformational changes in active center residues (I helix) implicated in proton pumping and dioxygen activation. Common conformational states among P450cam and homologous enzymes indicate that static and dynamic variability in the F/G helix region allows the 54 human P450s to oxidize thousands of substrates.

References

Feb 1, 1995·Nature Structural Biology·J R Cupp-Vickery, T L Poulos
Mar 4, 1994·Journal of Molecular Biology·C A HasemannJ Deisenhofer
Mar 1, 1996·Biopolymers·M F SannerJ C Spehner
Jan 14, 1997·Biochemistry·Y F UengF P Guengerich
Apr 1, 1997·Journal of Molecular Graphics & Modelling·R M Esnouf
Aug 1, 1997·Journal of Molecular Graphics & Modelling·B Bienfait, J Gasteiger
Oct 3, 1998·Acta Crystallographica. Section D, Biological Crystallography·A T BrüngerG L Warren
May 7, 1999·Journal of Medicinal Chemistry·E J JacobsenP S Kaytes
May 20, 1999·Annual Review of Pharmacology and Toxicology·F P Guengerich
Aug 18, 1999·Proceedings of the National Academy of Sciences of the United States of America·S Fischer, C S Verma
Aug 27, 1999·Archives of Biochemistry and Biophysics·D R Nelson
Nov 11, 1999·Proceedings of the National Academy of Sciences of the United States of America·I J DmochowskiH B Gray
Mar 4, 2000·Science·I SchlichtingS G Sligar
Jun 22, 2000·The Journal of Biological Chemistry·J K YanoT L Poulos
Mar 15, 2001·Proceedings of the National Academy of Sciences of the United States of America·L M PodustM R Waterman
Jan 1, 1995·Acta Crystallographica. Section D, Biological Crystallography·H Li, T L Poulos
Jan 1, 1997·Methods in Enzymology·E A Merritt, D J Bacon
Jan 1, 1997·Methods in Enzymology·Zbyszek Otwinowski, Wladek Minor

❮ Previous
Next ❯

Citations

Dec 17, 2002·Current Opinion in Biotechnology·Vlada Urlacher, Rolf D Schmid
Mar 20, 2010·Biochemistry·Young-Tae LeeDavid B Goodin
Feb 20, 2009·Chemical Communications : Chem Comm·Eric Meggers
Sep 13, 2008·Proceedings of the National Academy of Sciences of the United States of America·Lenong LiXiaoqiang Wang
May 8, 2010·Antioxidants & Redox Signaling·Thomas C PochapskyMarina Dang
Jan 29, 2011·Protein Engineering, Design & Selection : PEDS·Gregor HoffmannMeike Ballschmiter
Feb 22, 2012·Acta Crystallographica. Section D, Biological Crystallography·Stephen G BellLuet Lok Wong
Jun 11, 2004·Annual Review of Biochemistry·Olena Pylypenko, Ilme Schlichting
Dec 21, 2004·The Journal of Chemical Physics·Luke Campbell, Shaul Mukamel
Oct 18, 2003·Proceedings of the National Academy of Sciences of the United States of America·Emily E ScottC David Stout
Sep 15, 2005·Proceedings of the National Academy of Sciences of the United States of America·Stephen M ContakesHans C Freeman
Jul 4, 2007·Proceedings of the National Academy of Sciences of the United States of America·Masatomo MakinoShingo Nagano
Mar 27, 2003·Proceedings of the National Academy of Sciences of the United States of America·Harry B Gray
May 7, 2013·Journal of Bioscience and Bioengineering·Yuhei OshibaTakeo Yamaguchi
Jul 9, 2004·Drug Metabolism Reviews·F Peter Guengerich
Jul 2, 2015·Proceedings of the National Academy of Sciences of the United States of America·Simon P SkinnerMarcellus Ubbink
Feb 2, 2013·Journal of Bioscience and Bioengineering·Yuhei OshibaTakeo Yamaguchi
Jul 9, 2013·Protein Science : a Publication of the Protein Society·Shabana VohraPhilip C Biggin
Apr 3, 2007·Protein Science : a Publication of the Protein Society·Liliane MouawadDaniel Lavalette
Nov 4, 2004·Journal of Molecular Biology·Anna-Maria A HaysDavid B Goodin
Jul 28, 2016·Journal of the American Chemical Society·Shu-Hao LiouDavid B Goodin
Dec 3, 2005·Archives of Biochemistry and Biophysics·Michael J TrnkaWilliam F Trager
Jul 22, 2014·Journal of Computational Chemistry·Laura J Kingsley, Markus A Lill
Jan 26, 2017·Dalton Transactions : an International Journal of Inorganic Chemistry·Ana ZamoraEdith C Glazer
Dec 15, 2010·Chembiochem : a European Journal of Chemical Biology·Ming MaZihe Rao
Dec 14, 2011·Chembiochem : a European Journal of Chemical Biology·Hiroshi TakayamaNaoki Kanoh
Feb 12, 2015·The Journal of Biological Chemistry·Debashree BasudharPaul R Ortiz de Montellano
Feb 6, 2021·Biophysical Journal·Sashary RamosMegan C Thielges
Mar 7, 2021·Biophysical Journal·Bhupendra R DandekarJagannath Mondal
Mar 7, 2009·Chemical Reviews·Stefan Balaz
Jun 9, 2005·Chemical Reviews·Konrad SzaciłowskiGrazyna Stochel

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.